Additionally, the levels of HO-1 gene expression were measured in spleens harvested from the experimental groups used in Figure 5E. Quantification of bioluminescence values shows a significantly lowered tumor burden after brusatol and quizartinib treatment (Figure 5F). The gene discussed is HMOX1; the disease is neoplasm.